Your browser doesn't support javascript.
loading
Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms.
Gángó, Ambrus; Mózes, Réka; Boha, Zsófia; Kajtár, Béla; Timár, Botond; Király, Péter Attila; Kiss, Richárd; Fésüs, Viktória; Nagy, Noémi; Demeter, Judit; Körösmezey, Gábor; Borbényi, Zita; Marton, Imelda; Szoke, Anita; Masszi, Tamás; Farkas, Péter; Várkonyi, Judit; Plander, Márk; Pósfai, Éva; Egyed, Miklós; Pál, Katalin; Radványi, Gáspár; Hamed, Aryan; Csomor, Judit; Matolcsy, András; Alpár, Donát; Bödör, Csaba.
Affiliation
  • Gángó A; MTA-SE Lendület Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Mózes R; MTA-SE Lendület Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Boha Z; MTA-SE Lendület Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Kajtár B; Department of Pathology, University of Pécs, Pécs, Hungary.
  • Timár B; MTA-SE Lendület Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Király PA; MTA-SE Lendület Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary; 1st Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Kiss R; MTA-SE Lendület Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Fésüs V; MTA-SE Lendület Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Nagy N; MTA-SE Lendület Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Demeter J; 1st Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Körösmezey G; 1st Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Borbényi Z; 2nd Department of Internal Medicine and Cardiology Center, University of Szeged, Szeged, Hungary.
  • Marton I; 2nd Department of Internal Medicine and Cardiology Center, University of Szeged, Szeged, Hungary.
  • Szoke A; 2nd Department of Internal Medicine and Cardiology Center, University of Szeged, Szeged, Hungary.
  • Masszi T; 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Farkas P; 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Várkonyi J; 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Plander M; Markusovszky Teaching Hospital, Szombathely, Hungary.
  • Pósfai É; 2nd Department of Internal Medicine and Cardiology Center, University of Szeged, Szeged, Hungary.
  • Egyed M; Mór Kaposi Teaching Hospital of County Somogy, Kaposvár, Hungary.
  • Pál K; Szent György Teaching Hospital of County Fejér, Székesfehérvár, Hungary.
  • Radványi G; Teaching Hospital of County Borsod-Abaúj-Zemplén, Miskolc, Hungary.
  • Hamed A; Aladár Petz Teaching Hospital, Gyor, Hungary.
  • Csomor J; MTA-SE Lendület Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Matolcsy A; MTA-SE Lendület Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Alpár D; MTA-SE Lendület Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Bödör C; MTA-SE Lendület Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary. Electronic address: bodor.csaba1@med.semmelweis-univ.hu.
Leuk Res ; 65: 42-48, 2018 02.
Article in En | MEDLINE | ID: mdl-29306106
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Philadelphia Chromosome / Calreticulin / Janus Kinase 2 / Primary Myelofibrosis / Thrombocythemia, Essential / Mutation Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Leuk Res Year: 2018 Document type: Article Affiliation country: Hungria Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Philadelphia Chromosome / Calreticulin / Janus Kinase 2 / Primary Myelofibrosis / Thrombocythemia, Essential / Mutation Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Leuk Res Year: 2018 Document type: Article Affiliation country: Hungria Country of publication: Reino Unido